News
-
-
-
-
PRESS RELEASE
Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million
Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted -
PRESS RELEASE
Aurubis AG: Aurubis investing € 40 million in more independent and efficient production in Lünen
Aurubis AG invests €40 million in constructing an air separation unit at the Lünen plant, aiming for more independent and efficient production. The ASU will reduce CO2 emissions and enhance oxygen production -
-
-
-
-
